CD8A and neoplasm: In the tumor microenvironment, programmed death ligand 1 (PD-L1), which is a B7 family ligand, can bind to its receptor programmed death-1 (PD-1) to influence tumor-specific T cells, induce apoptosis, and inhibit the activity of CD8+ T cells, leading to immune evasion in tumors [11].